Get the Stockscreener App
10.98
2.96%
0.316
After Hours:
10.98
0.004
+0.04%
Envveno Medical Corporation stock is traded at $10.98, with a volume of 11,521.
It is up +2.96% in the last 24 hours and up +6.05% over the past month.
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.
See More
Previous Close:
$10.66
Open:
$10.89
24h Volume:
11,521
Relative Volume:
0.54
Market Cap:
$7.20M
Revenue:
-
Net Income/Loss:
$-21.97M
P/E Ratio:
-0.3425
EPS:
-32.0476
Net Cash Flow:
$-17.24M
1W Performance:
-4.72%
1M Performance:
+6.05%
6M Performance:
-67.23%
1Y Performance:
-89.33%
1-Day Range:
$10.75
$11.53
1-Week Range:
$9.91
$12.30
52-Week Range:
$8.67
$196.70
Envveno Medical Corporation Stock (NVNO) Company Profile
Name
Envveno Medical Corporation
Sector
Industry
Phone
949-261-2900
Address
70 DOPPLER, IRVINE
Compare NVNO vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NVNO
Envveno Medical Corporation
|
10.98 | 6.99M | 0 | -21.97M | -17.24M | -32.05 |
ABT
Abbott Laboratories
|
104.83 | 180.82B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
327.65 | 125.72B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.89 | 111.16B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
69.78 | 101.28B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
82.67 | 47.45B | 6.07B | 1.06B | 1.34B | 1.8063 |
Envveno Medical Corporation Stock (NVNO) Latest News
If You Invested $1,000 in Envveno Medical Corporation (NVNO) - Stock Titan
enVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement - Wilmington Star-News
NVNO's Shares Decline on Unfavorable FDA Review Outcome for VenoValve - MSN
Insider Sell: Francis Duhay Sells Shares of enVVeno Medical Corp (NVNO) - GuruFocus
[144] enVVeno Medical Corp SEC Filing - Stock Titan
Volatility Watch: Is enVVeno Medical Corporation a strong candidate for buy and hold2026 Spike Watch & Safe Capital Preservation Plans - baoquankhu1.vn
enVVeno Medical (NVNO) Stock Analysis Report | Financials & Insights - Benzinga Japan
NorthStrive Fund II LP Calls on enVVeno Medical to Halt Clinical Spending Plans and Call Special Shareholder Meeting to Vote on Strategic Alternatives - The Manila Times
Reviewing Pressure BioSciences (OTCMKTS:PBIO) & enVVeno Medical (NASDAQ:NVNO) - Defense World
NVNO SEC FilingsEnvveno Medical Corporation 10-K, 10-Q, 8-K Forms - Stock Titan
NVNO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Can enVVeno Medical Corporation maintain sales growthQuarterly Profit Summary & Daily Growth Stock Tips - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
enVVeno Medical (NVNO) investor urges halt to trials, strategic review - Stock Titan
enVVeno Medical Announces Reverse Stock Split - Press & Sun-Bulletin
Perceptive funds hold 2.05M enVVeno (NVNO) shares and warrants - Stock Titan
NVNO Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Strategic Investor Acquires Significant Stake in enVVeno Medical - AD HOC NEWS
Investor Braeden Lichti discloses 5.05% enVVeno (NVNO) ownership stake - Stock Titan
Aug Analyst Calls: Is enVVeno Medical Corporation a strong candidate for buy and hold2025 Risk Factors & Short-Term High Return Ideas - baoquankhu1.vn
Head to Head Analysis: LENSAR (NASDAQ:LNSR) versus enVVeno Medical (NASDAQ:NVNO) - Defense World
enVVeno Receives Unfavorable Appeal Decision from the FDA for the VenoValve - The Northwest Florida Daily News
enVVeno Medical (NASDAQ:NVNO) to Participate in a Live Virtual Investor CEO Connect Segment - DelmarvaNow.com
enVVeno Medical Regains Nasdaq Compliance, Supports 2026 Plans - The Globe and Mail
EnVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement - News Channel Nebraska Southeast
enVVeno Medical regains Nasdaq compliance, reports $28 million cash By Investing.com - Investing.com Nigeria
enVVeno Medical regains compliance with Nasdaq minimum bid price rule - TipRanks
enVVeno Medical Regains Nasdaq Compliance - Orange County Business Journal
Envveno Medical Corporation Stock (NVNO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):